Effect of tanezumab on joint pain, physical function, and patient global assessment of osteoarthritis among patients with osteoarthritis of the hip or knee: a randomized clinical trial
That gradual drop contributes to reduced muscle mass, slower recovery, fragmented sleep, and lower daytime energy
FDA-approved GLP-1 injections produce 14.9% to 20.9% body weight loss in rigorous clinical trials involving thousands of patients
It is expected to affect almost one in two adults by 2030 [3]
The conglomerate has a presence across the pharma value chain from manufacturing to diagnostics and medical devices
MYC-driven cancer cells exhibit enhanced glutamine utilization accompanied by increased expression of key glutaminolysis enzymes, including GLS1/GLS2 and GLUD1 178,179,180